Russia may use Saudi Arabia as a trial site for its experimental coronavirus vaccine, the head of Moscow’s sovereign wealth fund said this week.
A 100-person trial of a Russian-manufactured vaccine is currently underway in Russia, with a previous month-long trial involving 38 people having wrapped up this week. CEO of the Russian Direct Investment Fund Kirill Dmitriev said Saudi Arabia could be part of the next phase of testing in August, reports Arab News.